Chiesi Farmaceutici is a research-focused international group with more than 85 years of experience and is headquartered in Parma (Italy). Chiesi research, develops and markets innovative drugs for respiratory treatment, special care and rare diseases.
We are among the top 50 pharmaceutical companies in the world. Our production activity takes place in 3 plants located in Parma (Italy), Blois (France) and Santana de Parnaiba (Brazil).
The Group’s R&D Centre is based in Parma and works alongside 5 other important research and development centres in France, the U.S., Canada, the UK and Sweden to promote its pre-clinical, clinical and regulatory programmes. The Group employs more than 6,000 people.
Chiesi is the largest global pharmaceutical group to be awarded B Corp Certification; a recognition of high social and environmental standards. It feels natural: caring for others is at the root of health science and it has always been at the core of our work.
The Company is also committed to becoming carbon neutral, generating zero impact on the environment, by the end of 2035.